Euan Murray (Senior Scientist) will present the latest update on Elasmogen’s super-potent soloMER drug conjugate targeting the TNF-α and JAK pathways, advancing new possibilities for the treatment of autoimmune and inflammatory diseases at ELRIG, The Drug Discovery Community’s, Scottish Forum on Wednesday 17th of September.
ELRIG will be hosted at the CRUK Scotland Institute (Beatson Institute) in Glasgow. The forum will bring together experts in the field of drug discovery to discuss advances in small molecules, biologics, and cell therapies. The focus will be on the innovative and thriving life sciences sector based in Scotland, of which Elasmogen is proud to be a part of.